Syncom Formulations Intrinsic Value
SYNCOMF Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹15.84 | ₹12.67 - ₹19.01 | +13.4% | EPS: ₹0.72, Sector P/E: 22x |
| Book Value Method | asset | ₹34.93 | ₹31.44 - ₹38.42 | +150.0% | Book Value/Share: ₹36.38, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹27.94 | ₹25.15 - ₹30.73 | +100.0% | Revenue/Share: ₹54.04, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹27.94 | ₹25.15 - ₹30.73 | +100.0% | EBITDA: ₹96.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹33.24 | ₹26.59 - ₹39.89 | +137.9% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹4.61 | ₹4.15 - ₹5.07 | -67.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹11.12 | ₹10.01 - ₹12.23 | -20.4% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹27.94 | ₹25.15 - ₹30.73 | +100.0% | ROE: 19.9%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹24.28 | ₹21.85 - ₹26.71 | +73.8% | EPS: ₹0.72, BVPS: ₹36.38 |
Want to compare with current market value? Check SYNCOMF share price latest .
Valuation Comparison Chart
SYNCOMF Intrinsic Value Analysis
What is the intrinsic value of SYNCOMF?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Syncom Formulations (SYNCOMF) is ₹27.94 (median value). With the current market price of ₹13.97, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹4.61 to ₹34.93, indicating ₹4.61 - ₹34.93.
Is SYNCOMF undervalued or overvalued?
Based on our multi-method analysis, Syncom Formulations (SYNCOMF) appears to be trading below calculated value by approximately 100.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 22.50 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.21 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 19.9% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 15.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.23x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Syncom Formulations
Additional stock information and data for SYNCOMF
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹23 Cr | ₹14 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹-6 Cr | ₹-6 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹11 Cr | ₹-12 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹16 Cr | ₹3 Cr | Positive Free Cash Flow | 7/10 |
| March 2017 | ₹14 Cr | ₹5 Cr | Positive Free Cash Flow | 7/10 |